Telo Genomics Corp. (TDSGF)

USD 0.06

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 33.11 Thousand 56.95 Thousand 62.22 Thousand 64.71 Thousand 82.9 Thousand 124.32 Thousand
Gross Profit -33.11 Thousand -56.95 Thousand -62.22 Thousand -64.71 Thousand -82.9 Thousand -124.32 Thousand
Operating Expenses 2.88 Million 2.11 Million 1.25 Million 1.31 Million 1.05 Million 4.6 Million
Selling, General and Administrative Expenses 1.52 Million 986.62 Thousand 653.29 Thousand 946.11 Thousand 856.74 Thousand 3.06 Million
Research and Development Expenses 1.36 Million 1.12 Million 603.9 Thousand 364.74 Thousand 196.77 Thousand 1.54 Million
Other Expenses - - 183.48 Thousand 95.69 Thousand - 11.71 Thousand
Cost and Expenses 2.88 Million 2.11 Million 1.25 Million 1.31 Million 1.05 Million 4.6 Million
Operating Income -2.88 Million -2.11 Million -1.07 Million -1.21 Million -1.05 Million -4.5 Million
Interest Expense 5206.00 5390.00 - 26.53 Thousand 20.67 Thousand -
Income Tax Expense - -5394.00 183.48 Thousand 122.23 Thousand -88.95 Thousand 98.54 Thousand
Earnings before Tax -2.82 Million -2.11 Million -1.06 Million -1.24 Million -1.07 Million -4.69 Million
Net Income -2.82 Million -2.11 Million -1.06 Million -1.24 Million -1.07 Million -4.69 Million
Earnings Per Share Basic -0.05 -0.04 -0.02 -0.04 -0.08 -0.08
Earnings Per Share Diluted -0.05 -0.04 -0.02 -0.04 -0.08 -0.08
Weighted Average Shares Outstanding 60.15 Million 58.66 Million 46.88 Million 29.92 Million 13.22 Million 59.76 Million
Weighted Average Shares Outstanding (Diluted) 60.15 Million 58.66 Million 46.88 Million 29.92 Million 13.22 Million 59.76 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -2.78 Million -2.05 Million -1.19 Million -1.15 Million -970.61 Thousand -4.38 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts